1. Home
  2. CNVS vs TVGN Comparison

CNVS vs TVGN Comparison

Compare CNVS & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$2.64

Market Cap

56.6M

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$7.49

Market Cap

63.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNVS
TVGN
Founded
2000
2020
Country
United States
United States
Employees
218
N/A
Industry
Consumer Electronics/Video Chains
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
56.6M
63.9M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CNVS
TVGN
Price
$2.64
$7.49
Analyst Decision
Buy
Hold
Analyst Count
1
1
Target Price
$9.00
N/A
AVG Volume (30 Days)
146.2K
17.3K
Earning Date
02-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
108.99
N/A
EPS
N/A
N/A
Revenue
$78,181,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$84.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
59.13
N/A
52 Week Low
$1.77
$0.14
52 Week High
$7.39
$10.76

Technical Indicators

Market Signals
Indicator
CNVS
TVGN
Relative Strength Index (RSI) 58.57 60.32
Support Level $2.31 $0.47
Resistance Level $3.47 $9.40
Average True Range (ATR) 0.15 0.80
MACD 0.03 -0.09
Stochastic Oscillator 79.57 36.33

Price Performance

Historical Comparison
CNVS
TVGN

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: